Innovation

Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…

Out of sight and out of mind in a ditch around an hour-and-a-half drive from Townsville, sits an…

In a viral essay on X, “Something Big Is Happening,” Matt Shumer writes that the world is living…

Flour Mills of Nigeria (FMN) has opened applications for the fifth edition of its annual Prize for Innovation…

Cash App introduced a peer-to-peer payment feature designed to simplify money requests. The company’s new payment links service…

It’s February 2020 again. An exponential process is in motion — one that will inevitably shake the world…

Opinions expressed by Entrepreneur contributors are their own. Key Takeaways Breakthroughs emerge by collapsing false constraints through integrated…

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites…

Some smart people think we’re witnessing another ChatGPT moment. This time, folks aren’t flipping out over an iPhone…

There’s something sad about seeing a humanoid robot lying on the floor. Without any electricity, these bipedal machines…

Chinese scientists have pushed solid-state vacuum ultraviolet laser technology to a new milestone by achieving a record-short wavelength…

Steve Jobs (1955–2011) was an American entrepreneur, inventor, and visionary, best known as the co-founder of Apple Inc.…

Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)